Pharmaceutical marketing in UAE has been growing in recent years due to the country's increasing population and high standard of living. The question is whether the existing strategy for pharmaceutical marketing will be effective in the rapidly changing environment of patient advocacy, preventative care, and strict requirements for outcome verification. However, we believe pharmaceutical marketing in UAE has a promising future.
UAE has a highly developed healthcare system, and many residents have private health insurance. Pharmaceutical companies can utilize this opportunity by marketing their products to private hospitals and clinics. In addition, the UAE has a high level of internet penetration, which provides another avenue for pharmaceutical marketing.
The one-size-fits-all strategy will no longer be effective
Traditional marketing tactics in this sector have centered on aggressively promoting prescription medications that decision-makers believe would generate revenue. Aggressive digital marketing and promotional efforts are typically directed at physicians and are credited with commercial success. The primary objective hasn't always been to meet the needs and expectations of patients, providers, and payers, but that's about to change.
Pharmaceutical marketing is complicated and often follows two routes: direct-to-consumer or direct-to-provider/payer. Unfortunately, nowadays, pharmaceutical companies rarely make a distinction between these two channels.
They frequently adopt a one-size-fits-all strategy. This is contrary to current thinking, which emphasizes personalization, customer experience, and targeted omnichannel marketing utilizing the appropriate product, at the proper time, for the relevant user, and with the suitable media.
Value-based healthcare is now the norm
More value than ever is expected from pharmaceutical makers in our rapidly evolving industry. Value in this context refers to increased cost-effectiveness, validated patient outcomes, and increased value added along the entire value chain to the patient experience.
Value-based health care continues to be hampered by the strict regulations and environment around pharmaceutical marketing. Notably, little evidence points to a quick improvement in the regulatory environment for marketing pharmaceuticals.
A multidisciplinary strategy for providing healthcare
The healthcare system is adopting a multidisciplinary approach to healthcare in response to the developing trend toward integrated health management. Pharmaceutical companies are responding with more individualized, enhanced products tailored to satisfy patients' unique needs across the healthcare value chain.
In addition, the country's strategic location and status as a regional hub for trade and commerce make it an attractive market for pharmaceutical companies.
However, the UAE's pharmaceutical market is still in its early stages of development and lacks regulations and guidelines governing pharmaceutical marketing practices. Therefore, it can create challenges for companies that want to enter pharmaceutical marketing in UAE.
We at Pharmadeel provide pharmaceutical consultancy and medical services in UAE, such as cosmetics, skincare products, pharmaceuticals, vitamins & supplements, nutrition, gym & fitness equipment, etc., at affordable costs.
